Compound ID | 203
Class: 3-hydrazinoquinoxaline-2-thiol
Spectrum of activity: | Gram-negative |
Details of activity: | Helicobacter pylori - Unknown mechanism of action |
Institute where first reported: | Arietis Pharma, Boston, Massachusetts, USA |
Year first mentioned: | 2014 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/781248 |
Citations: |
|